4-N-Hydroxy-4-[1-(sulfonyl)piperidin-4-yl]-butyramides as HDAC inhibitors
Authors:
- Christopher I. FinchamCFChristopher I. Fincham
- Piero D’aNdreaPDPiero D’aNdrea
- Marina PorcelloniMPMarina Porcelloni
- Alessandro EttorreAEAlessandro Ettorre
- Sandro MauroSMSandro Mauro
- Mario BigioniMBMario Bigioni
- Monica BinaschiMBMonica Binaschi
- Carlo A. MaggiCMCarlo A. Maggi
- Federica NardelliFNFederica Nardelli
- Massimo ParlaniMPMassimo Parlani
- Daniela FattoriDFDaniela Fattori
- 1 November 2011
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 21 (22) , 6767-6769
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Alkyl piperidine and piperazine hydroxamic acids as HDAC inhibitorsBioorganic & Medicinal Chemistry Letters, 2011
- Histone acetyltransferase inhibitors and preclinical studiesExpert Opinion on Therapeutic Patents, 2009
- Histone Deacetylase Inhibitors: From Bench to ClinicJournal of Medicinal Chemistry, 2008
- Anticancer activities of histone deacetylase inhibitorsNature Reviews Drug Discovery, 2006
- Efficient synthesis of arylsulfamides by reaction of amines with arylsulfamoyl imidazolium triflateTetrahedron Letters, 2005